Ischemic biomarker heart-type fatty acid binding protein (hFABP) in acute heart failure - diagnostic and prognostic insights compared to NT-proBNP and troponin I [PDF]
, 2015 Background: To evaluate diagnostic and long-term prognostic values of hFABP compared to NT-proBNP and troponin I (TnI) in patients presenting to the emergency department (ED) suspected of acute heart failure (AHF).
Ahmad-Nejad, Parviz +9 more
core +1 more source
Diagnostic performance and reference values of novel biomarkers of paediatric heart failure [PDF]
, 2016 Objective: Biomarkers play a pivotal role in heart failure (HF) management. Reference values and insights from studies in adults cannot be extrapolated to the paediatric population due to important differences in pathophysiology and compensatory reserve.
Burch, M +11 more
core +1 more source
The integration of BNP and NT-proBNP into clinical medicine
Swiss Medical Weekly, 2007 B-type natriuretic peptide (BNP) and NTproBNP have been shown to be extremely helpful in the diagnosis and management of patients with heart failure (HF). These neurohormones are predominately secreted from the left and the right cardiac ventricle in response to volume and pressure overload.
Christian, Mueller +4 more
openaire +3 more sources
Italian National Conference on Sensors, 2019 Surface-plasmon-resonance (SPR) is a quantum-electromagnetic phenomenon arising from the interaction of light with free electrons at a metal-dielectric interface.
Dorin Harpaz +5 more
semanticscholar +1 more source
Effect of atrioventricular optimization on circulating N-terminal pro brain natriuretic peptide following cardiac resynchronization therapy. [PDF]
, 2013 AIMS: Following CRT, atrioventricular (AV) optimization is not routinely practised. To evaluate its clinical utility, we examined the effect of AV delay optimization on the prognostic biomarker NT-proBNP.
Abraham +36 more
core +1 more source
The effects of short-term omission of daily medication on the pathophysiology of heart failure [PDF]
, 2016 Aims Pharmacological therapies for heart failure (HF) aim to improve congestion, symptoms, and prognosis. Failing to take medication is a potential cause of worsening HF.
Abraham +31 more
core +4 more sources
Natriureetiline propeptiid – täiendav võimalus müokardiinfarktiga patsiendi prognoosi hindamisel [PDF]
, 2006 Natriureetilised peptiidid on peptiidhormoonid, mida sünteesitakse südamelihases vas tu sena südame seina pinge ja plasmamahu suurenemisele. NT-proBNP on B-tüüpi natriureeti lise peptiidi (BNP) N-terminaalne propeptiid, millel ei ole füsioloogilist ak ...
Ainla, Tiia +4 more
core +2 more sources
N-terminal pro-B-type natriuretic peptide and functional capacity in patients with obstructive sleep apnea [PDF]
, 2018 The obstructive sleep apnea syndrome (OSAS) is associated with cardiovascular abnormalities including left ventricular hypertrophy, left ventricular diastolic dysfunction, and endothelial dysfunction.
Ammann, Peter +7 more
core
NT-proBNP (N-Terminal Pro-B-Type Natriuretic Peptide) and the Risk of Stroke.
Stroke, 2019 Background and Purpose- NT-proBNP (N-terminal pro-B-type natriuretic peptide) is a risk factor for atrial fibrillation and a marker of cardiac function used in the detection of heart failure.
A. Di Castelnuovo +17 more
semanticscholar +1 more source
Cardiac Biomarker Release After Exercise in Healthy Children and Adolescents: A Systematic Review and Meta-Analysis. [PDF]
, 2018 PURPOSE: The authors evaluated the impact of acute exercise and 24-hour recovery on serum concentration of cardiac troponins T and I (cTnT and cTnI) and N-terminal fragment of the prohormone brain natriuretic peptide (NT-proBNP) in healthy children and ...
Alquézar Arbé +165 more
core +4 more sources